Skip to main content
Top
Published in: Abdominal Radiology 2/2019

01-02-2019 | Classics in Abdominal Radiology

The “burnt-out” testicular (Azzopardi) tumor

Authors: Teresa S. McQueen, Raymond B. Dyer

Published in: Abdominal Radiology | Issue 2/2019

Login to get access

Excerpt

In males, primary germ cell tumors typically present as a testicular mass [1]. On a few occasions, the primary testicular tumor can regress leaving behind only residual testicular scarring, despite the presence of widespread metastatic disease. This scenario represents a “burnt-out” testicular tumor, also known eponymously as an “Azzopardi tumor” (Fig. 1) [2]. In 1961, Azzopardi et al. reported a series of 17 cases of young men who died of metastatic germ cell tumors, in whom the primary testicular lesion was a fibrous scar with minimal or no viable neoplastic tissue, when examined pathologically [2]. These scars often contained calcium, and it was theorized that the primary tumor had infarcted due its propensity for local vascular invasion, with the resulting necrotic area forming a matrix conducive to calcium deposition [2]. When the “burnt-out” appearance is identified sonographically, it should prompt evaluation of the chest, abdomen, and pelvis for metastatic deposits (Fig. 2).
Literature
1.
go back to reference Predo O, Nicolae A, Loghin A, Borda A, Nogales FF (2011) Retroperitoneal seminoma as a first manifestation of a partially regressed (burnt-out) testicular germ cell tumor. Rom J Morphol Embryol 52(1):193–196 Predo O, Nicolae A, Loghin A, Borda A, Nogales FF (2011) Retroperitoneal seminoma as a first manifestation of a partially regressed (burnt-out) testicular germ cell tumor. Rom J Morphol Embryol 52(1):193–196
2.
go back to reference Azzopardi JG, Mostofi FK, Theiss EA (1961) Lesions of testes observed in certain patients with widespread choriocarcinoma and related tumors. Am J Pathol 38:207–225PubMedPubMedCentral Azzopardi JG, Mostofi FK, Theiss EA (1961) Lesions of testes observed in certain patients with widespread choriocarcinoma and related tumors. Am J Pathol 38:207–225PubMedPubMedCentral
3.
go back to reference Nakazaki H, Tokuyasu H, Takemoto Y, et al. (2016) Pulmonary metastatic choriocarcinoma from a burned-out testicular tumor. Intern Med 55(11):1481–1485CrossRefPubMed Nakazaki H, Tokuyasu H, Takemoto Y, et al. (2016) Pulmonary metastatic choriocarcinoma from a burned-out testicular tumor. Intern Med 55(11):1481–1485CrossRefPubMed
4.
go back to reference Qureshi JM, Feldman M, Wood H (2014) Metastatic “burned-out” germ cell tumor of the testis. J Urol 192(3):936–937CrossRefPubMed Qureshi JM, Feldman M, Wood H (2014) Metastatic “burned-out” germ cell tumor of the testis. J Urol 192(3):936–937CrossRefPubMed
5.
go back to reference Tasu JP, Fayne N, Eschwege P, Rocher L, Biery M (2003) Imaging of burned out testis tumor: five new cases and review of the literature. J Ultrasound Med 22(5):515–521CrossRefPubMed Tasu JP, Fayne N, Eschwege P, Rocher L, Biery M (2003) Imaging of burned out testis tumor: five new cases and review of the literature. J Ultrasound Med 22(5):515–521CrossRefPubMed
Metadata
Title
The “burnt-out” testicular (Azzopardi) tumor
Authors
Teresa S. McQueen
Raymond B. Dyer
Publication date
01-02-2019
Publisher
Springer US
Published in
Abdominal Radiology / Issue 2/2019
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-018-1760-4

Other articles of this Issue 2/2019

Abdominal Radiology 2/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.